TrialThe Lancet. Neurology2021

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.

Patrick Gavin Kehoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.